The goal of this randomized clinical trial is to investigate whether pressurized intraperitoneal chemotherapy (PIPAC), delivered immediately after minimally in…

Gastric CancerChemotherapy, AdjuvantPeritoneal Metastases+1 more

~Estimated

~$10 – $6,250

Odense University HospitalNCT06295094

Coordination of Rare Diseases at Sanford

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, …

Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more

Phase 2

The 'SWIVEL' Study (Switch Vs Effects Relief): Effectiveness of a Medication 'Switch' vs Guideline-Directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients

Researchers have learned that about 50% of women do not finish the standard 5-year breast cancer treatment with an aromatase inhibitor. An aromatase inhibitor …

Breast CancerAdjuvant TreatmentEarly Stage Breast Cancer

~Estimated

~$10 – $6,250

Dartmouth-Hitchcock Medical CenterNCT07071038

Phase 1

Contrast Enhanced Digital Mammography for Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy

The purpose of this study is to compare a special type of mammogram that uses a contrast agent called contrast-enhanced digital mammography with contrast-enhan…

Breast CancerLocally Advanced Breast CancerNeoadjuvant Chemotherapy+3 more

~Estimated

~$10 – $7,500

Alison StopeckNCT06220214

← PreviousPage 2 of 2Next →

~Estimated

~$10 – $1,125

Sanford HealthNCT01793168